vs

Side-by-side financial comparison of AURORA CANNABIS INC (ACB) and Regencell Bioscience Holdings Ltd (RGC). Click either name above to swap in a different company.

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. ...

Regencell Bioscience Holdings Ltd is a specialized bioscience enterprise focused on the research, development and commercialization of therapeutic products derived from traditional Chinese medicine. Its core pipeline targets neurodegenerative, immunological and infectious disease treatments, with primary operating markets across Greater China and other Asian regions.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACB
ACB
RGC
RGC
Q4 25
$94.2K
Q1 25
$90.5K
Q1 24
$45.6K
Q2 23
$81.6M
Net Profit
ACB
ACB
RGC
RGC
Q4 25
$-1.7K
Q1 25
Q1 24
Q2 23
$-617.0M
Gross Margin
ACB
ACB
RGC
RGC
Q4 25
Q1 25
Q1 24
54.0%
Q2 23
8.7%
Operating Margin
ACB
ACB
RGC
RGC
Q4 25
Q1 25
Q1 24
Q2 23
-73.7%
Net Margin
ACB
ACB
RGC
RGC
Q4 25
-1.9%
Q1 25
Q1 24
Q2 23
-756.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons